IIQASXInoviq Ltd

IIQ price activity

Last Price

Change (24hr)

AUD (%)

Volume

Volume (4w avg)

Previous Close

N/A

Last Trade

IIQ price performance

-5.13%

-7.5%

-52.26%

YTD

-53.75%

IIQ price fundamentals

N/A

Shares Issued

N/A

Earnings Per Share (EPS)

N/A

Dividends Per Share (DPS)

N/A

P/E Ratio

Price market cap

Market cap

N/A

AU-ASX rank

N/A

Sector Rank

N/A

IIQ details

View company website

View AU-ASX Official Page

IIQ dividends

IIQ Market Signals

More ways to discover

Browse Australia news Discover ASX signals Browse all ASX stocks Browse all ASX ETFs

Inoviq Ltd (AU-ASX: IIQ)

INOVIQ Ltd develops and commercializes diagnostic and exosome-based products to enhance the diagnosis and treatment of cancer and other diseases in Australia and the United States. It offers hTERT ICC test, an immunocytochemistry test used as an adjunct to urine cytology testing for bladder cancer; and EXO-NET, an EV isolation tool for biomarker discovery and diagnostic development. It offers non-invasive, diagnostics using its proprietary exosome develops technologies for improved screening, diagnosis, treatment selection and monitoring of cancer and other diseases. The company was formerly known as BARD1 Life Sciences Limited and changed its name to INOVIQ Ltd in December 2021. INOVIQ Ltd was founded in 2016 and is headquartered in Notting Hill, Australia.

Price: A$0.19

Sector: Healthcare — Diagnostics & Research